It is the thing that makes stress bearable
however, if no important differences were observed, the FE model is preferred
In the SURMOUNT-5 triala head-to-head, open-label, randomized controlled studytirzepatide (Zepbound) was compared to semaglutide (Wegovy) in adults with obesity or overweight and at least one comorbidity (e.g., hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease), but without type 2 diabetes.(11) At maximum tolerated doses over 72 weeks, Zepbound resulted in a mean weight reduction of 20.3%, compared to 13.2% with Wegovy.(11) Patients on the highest dose of tirzepatide and semaglutide reported nausea (31%, 14.4%) and diarrhea (23%, 14%).(9) Tirzepatide is currently the only FDA-approved pharmacotherapy to achieve this level of weight loss
Keller MD, Nathan E Marshall MD, Jonathan Lynch MD, John-Michael Guest BA Terrance Lock MD, Brian Rill MD Patient Perceptions of Reimbursement for Arthroscopic Meniscectomy and ACL Reconstruction Orthopedics
Register now Subscribe to unlock unlimited access Get news, unique commentary, expert analysis and essential resources from the IAM experts
By replenishing glutathione levels through supplementation, we may help mitigate some of the oxidative damage associated with aging
